Closed

HPVITS2019-058.015 - HPVITS2019-058.015 Pharmaceutical Products and IV Fluids

Description

HSV has made an update to Supplementary 015. Please find the updated information as below.     HSV plans to release a tender for the supply of goods listed below:   Market Release Date: 14 July 2023 Market Closing Date: 4 August 2023 (14:00) SUBCATEG...

Categories

  • Bendamustine (12%)
  • Bivalirudin (8%)
  • Cefazolin or cefazoline or cephazolin (8%)
  • Cytarabine (8%)
  • Dexamethasone (8%)
  • Fosaprepitant or ivemend (8%)
  • Glycopyrrolate (8%)
  • Mesalamine or mesalazine (8%)
  • Nebivolol (8%)
  • Neostigmine (8%)
  • Sitagliptin (8%)
  • Valsartan (8%)

Specification documents

There are no specification documents for this tender.

See every tender in full

One Premium plan covers every opportunity across Australia and New Zealand.

  • Full details, briefings and documents
  • Buyer and contact details
  • Saved searches with full alerts
  • Track opportunities
  • Your full supplier profile

Premium

A$116.66/mo

Upgrade to Premium

Billed as a single annual payment of A$1,399.95 excl. GST